story of the week
Adjuvant Exemestane With Ovarian Suppression for Premenopausal Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
J. Clin. Oncol 2022 Dec 15;[EPub Ahead of Print], O Pagani, BA Walley, GF Fleming, M Colleoni, I Láng, HL Gomez, C Tondini, HJ Burstein, MP Goetz, EM Ciruelos, V Stearns, HR Bonnefoi, S Martino, CE Geyer, C Chini, F Puglisi, S Spazzapan, T Ruhstaller, EP Winer, B Ruepp, S Loi, AS Coates, RD Gelber, A Goldhirsch, MM Regan, PA FrancisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.